Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Busse
Prescription of DPP-4 Inhibitors to Type 2 Diabetes Mellitus Patients With Renal Impairment: A UK Primary Care Experience
Clinical Therapeutics
Pharmacology
Related publications
Systematic Literature Review of DPP-4 Inhibitors in Patients With Type 2 Diabetes Mellitus and Renal Impairment
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
Pdb101 - Therapy Adjustment in Adult T2dm Patients With Renal Impairment Treated With DPP-4 Inhibitors in the Uk: A Retrospective Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Emerging DPP-4 Inhibitors: Focus on Linagliptin for Type 2 Diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus
Frontiers in Pharmacology
Pharmacology
Use of DPP-4 Inhibitors in Type 2 Diabetes: Focus on Sitagliptin
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Managing Diabetic Patients With Moderate or Severe Renal Impairment Using DPP-4 Inhibitors: Focus on Vildagliptin
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Cost-Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors as an Add-On to Metformin in the Treatment of Type 2 Diabetes Mellitus From a UK Healthcare System Perspective
BMC Health Services Research
Health Policy
Association of Urinary Activity of MMP-9 With Renal Impairment in Mexican Patients With Type 2 Diabetes Mellitus
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
